GELS Gelteq Ltd

$0.48 +4.23%

Data as of Nov 4, 2026 close

Healthcare · Pharmaceutical Preparations

Gelteq Ltd (GELS) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $5 million. Shares last traded at $0.48, 76.1% below their 52-week high. Over the past year the stock is down 70.3%.

Market Cap

$5M

Shares Out

9.4M

EPS (TTM)

—

P/E (TTM)*

—

P/S Ratio

—

P/B Ratio

—

Dividend / Share

—

Dividend Yield

—

52-Week High

$2.01

52-Week Low

$0.39

Volume (venue)

306

Avg Vol (3m, venue)

39,899.302

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Gelteq Ltd reports in AUD: EPS, dividends and financials are shown in AUD as filed. P/E, P/S, P/B and yield convert them at 1 AUD = 0.7038 USD on 2026-10-30 (Federal Reserve H.10 via FRED, DEXUSAL).

Performance

+7.86%

-11.98%

-28.29%

-30.78%

YTD

-39.95%

-70.35%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

45.61

SMA (50)

$0.57

SMA (200)

$0.71

Price vs SMA50

-16.35%

Price vs SMA200

-32.64%

ATR (14)

$0.05

Full technical analysis (26 indicators, D/W/M) →

Pharmaceutical Preparations peers

GELS vs 14 industry peers (Pharmaceutical Preparations), by market cap. Data as of Nov 4, 2026 close

1–14 of 14


LLY	Lilly (Eli)	$1.33T	48.37	15.43	31.9%	+0.62%
JNJ	Johnson & Johnson	$665.2B	41.33	6.70	16.2%	+3.82%
ONC	Beone Medicines Ltd.	$558.0B	850.93	91.04	10.7%	+6.36%
ABBV	AbbVie	$521.3B	50.40	7.90	15.7%	+3.16%
MRK	Merck	$370.7B	151.12	5.50	3.6%	+3.93%
ABT	Abbott Laboratories	$200.2B	42.58	4.15	9.7%	+5.61%
PFE	Pfizer	$175.5B	43.52	2.76	6.3%	+2.70%
VRTX	Vertex Pharmaceuticals	$139.2B	35.01	10.75	30.7%	+3.37%
BMY	Bristol Myers Squibb	$131.2B	14.20	2.62	18.5%	+4.04%
REGN	Regeneron Pharmaceuticals	$96.3B	19.99	5.70	28.5%	-4.41%
TEVA	Teva Pharmaceutical Industries Ltd	$48.8B	96.39	2.83	2.9%	-0.24%
ZTS	Zoetis	$36.8B	14.08	3.87	27.5%	+7.40%
RPRX	Royalty Pharma Plc	$30.1B	44.80	11.50	25.7%	+1.82%
ROIV	Roivant Sciences Ltd.	$27.6B	—	3665.32	—	+5.99%

Source: SEC EDGAR (fundamentals/EPS/dividends, reported in AUD) · Databento EQUS.MINI (prices) · FX: 1 AUD = 0.7038 USD on 2026-10-30 (Federal Reserve H.10 via FRED, DEXUSAL) · market cap & yield computed by tradmap. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.